Express Scripts aims to ensure that patients directly benefit from its negotiations with drug manufacturers. The new approach will protect patients from paying inflated list prices for medications, ...

They are on this list for a reason. Cigna doesn't want to pay for quality ... including Healthcare Finance News, Hospitals & Health Networks, Managed Care magazine, Ophthalmology Management ...

In the wake of federal pressure over its prescription costs, Cigna Group is looking to lower the out-of-pocket drug expenses that its patients face by matching the amount to employer contributions and ...

Stryker Corporation SYK reported fourth-quarter 2024 adjusted earnings per share (EPS) of $4.01, which beat the Zacks ...

Cigna Group CEO David Cordani said the company will make investments this year to improve patient and provider experiences ...

Cigna blamed lower-than-expected fourth-quarter returns on its stop-loss insurance business that insures employers from ...

Cigna forecast annual profit below Wall Street expectations on Thursday and missed estimates for the fourth quarter, as ...

Shares of Cigna Group slid after the health insurer warned that higher health-care costs in one insurance unit weighed on profitability. Insurers saw profit margins soar in the pandemic as insurees ...

Cigna said its medical loss ratio was 87.9% in Q4 2024, compared to 82.2% in the prior-year quarter. For the full-year 2024, MLR was 83.2%, which was still higher compared to the 81.3% its insurance ...

Managed Healthcare Executive provides C-suite executives at health plans and provider organizations with news, analysis, ...

2022 The Cigna Group Registered Shs 4.48 1.35 USD 2021 The Cigna Group Registered Shs 4.00 1.74 USD 2020 The Cigna Group Registered Shs 0.04 0.02 USD 2019 The Cigna Group Registered Shs 0.04 0.02 ...

Vertex Pharmaceuticals won FDA approval for its non-opioid painkiller Journavx. Vertex stock jumped in late trading.